Citations

Mayo Clinic

Showing 10 of 108537 citations.

Predicting the unpredictable: a novel application of artificial intelligence in the cardiac intensive care unit
Jentzer, Jacob C. , Rosselló, Xavier , Jentzer, Jacob C

European Heart Journal: Acute Cardiovascular Care | May 16, 2024 | Volume: 13 | Issue: 6 | Pages: 481-483

10.1093/ehjacc/zuae065 | PMID 38757197 Get It

Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial
Liu, Joyce F. , Gaillard, Stéphanie , Hendrickson, Andrea E. Wahner , Yeku, Oladapo , Jackson, Camille Gunderson, Arend, Rebecca C. , Ratner, Elena , Samnotra, Vivek, Gupta, Divya , Chung, Jon , Zhang, Hailei , Compton, Natalie, Baines, Amanda, Bacqué, Emeline , Felicetti, Brunella, Konecny, Gottfried E. , Wahner Hendrickson, Andrea E , Konecny, Gottfried E , Gaillard, Stéphanie , Yeku, Oladapo O , Diver, Elisabeth , Liu, Xiaohong

JCO Precision Oncology | May 16, 2024 | Volume: No volume available | Issue: 8 | Pages: No page available

10.1200/po.23.00693 | PMID 38754056 Get It

PURPOSE To report the results of OPAL (ClinicalTrials.gov identifier: NCT03574779 ) cohort A, a single-arm substudy of niraparib plus dostarlimab and bevacizumab for the treatment of advanced, platinum-resistant ovarian cancer (PROC). METHODS Participants with PROC who received 1-2 previous lines of therapy were treated with niraparib (200 or 300 mg once daily), dostarlimab (500 mg once every 3 weeks for four 21-day cycles, followed by 1,000 mg once every 6 weeks), and bevacizumab (15 mg/kg once every 3 weeks). The primary end point was investigator-assessed objective response rate (ORR) per RECIST v1.1. Safety was also assessed. Exploratory biomarker end points included evaluation of changes in the tumor molecular profile and microenvironment using baseline and on-treatment tumor samples. RESULTS Of 41 enrolled participants (median age, 66.0 years [range, 37-83 years]), 9.8% had tumors that were BRCA-mutated, 19.5% were homologous recombination (HR)–deficient, and 17.1% were HR repair (HRR)–mutated. As of the cutoff date, all participants discontinued treatment. The ORR was 17.1% (80% CI, 9.8 to 27.0), including one complete response (2.4%); the disease control rate was 73.2% (80% CI, 62.3 to 82.2). Two participants withdrew before first postbaseline scan because of adverse events (AEs). Grade ≥3 treatment-emergent AEs were reported in 92.7% of participants, with the most common being hypertension (26.8%). Response was not correlated with BRCA, HRR, HR deficiency (HRD), or PD-L1 status. Changes suggesting immune activation were observed in on-treatment samples after triplet therapy. CONCLUSION Results demonstrated modest activity of niraparib, dostarlimab, and bevacizumab in participants with PROC, many of whom had prognostic factors for poor treatment response. Most participants with response were bevacizumab-naïve. No association was found with HRD, BRCA, or PD-L1 status. AEs were consistent with previous monotherapy reports, except that hypertension was reported more frequently.
A Goal-Writing Framework for Motor-Based Intervention for Childhood Apraxia of Speech
Case, Julie , Caspari, Susan S. , Stoeckel, Ruth , Stoeckel, Ruth , Aggarwal, Pooja

American Journal of Speech-Language Pathology | May 16, 2024 | Volume: 33 | Issue: 4 | Pages: 1590-1607

10.1044/2024_ajslp-24-00014 | PMID 38754036 Get It

Purpose: There are multiple frameworks for goal writing that are applicable to the practice of speech-language pathology. Motor-based speech disorders are a subset of speech sound disorders that are thought to require specific elements of intervention that are typically not addressed in the traditional frameworks used in the clinical setting. The purpose of this tutorial is to review general approaches of goal writing and suggest additional elements that may be used to improve the efficiency and effectiveness of treatment for childhood motor speech disorders, specifically childhood apraxia of speech (CAS). Method: Existing models of goal writing were reviewed to ascertain elements common to most of these models. A basic framework was chosen and modified to include behaviors, conditions, and approaches to goal measurement tailored to the clinical needs of children with CAS. A resource for clinical decision making for children with CAS was developed to inform goal writing at the onset of treatment and adaptations that occur over the course of treatment. Case studies are presented to demonstrate how the presented framework can be applied to writing goals for motor-based treatment for two different children with CAS. Discussion: Children with CAS require a specialized approach to intervention, which requires goals to reflect the unique clinical needs of this population. This tutorial offers resources that use the best available research evidence and current understanding of effective treatment practices for CAS to guide clinical decision making for motor-based intervention and goal writing. This tutorial is intended to guide treatment planning across varied settings to facilitate progress and optimize treatment outcomes for children with CAS.
Infected Thrombosis Leading to Veno-Venous Extracorporeal Membrane Oxygenation Dysfunction in Chronic Thromboembolic Pulmonary Hypertension
Grate, Jeremy C. , Reynolds, Tyler S. , Gordon, Adam C. , Dave, Sagar , Dave, Sagar B

ASAIO Journal | May 16, 2024 | Volume: 71 | Issue: 1 | Pages: e8-e11

10.1097/mat.0000000000002233 | PMID 38753559 Get It

Nosocomial infections and thrombosis are frequent complications during extracorporeal membrane oxygenation (ECMO). Preventative measures and close monitoring for early recognition of these complications are imperative in patients supported with ECMO. We report the case of a 41 year old female on veno-venous ECMO awaiting surgical thrombectomy for chronic thromboembolic pulmonary hypertension that developed profound bacteremia leading to gross purulence and thrombosis of the membrane oxygenator. Recannulation in addition to targeted antibiotics, frequent cultures, imaging, and surgery were diagnostic and therapeutic interventions that led to ultimate resolution.
Harnessing Auricular Lobule Redundancy: An Optimal Skin Graft Reservoir
McGuinness, Ashley E., Jing, Frank Z., Sidey, Kirk , Vidal, Nahid Y. , Jing, Frank Z.

Dermatologic Surgery | May 16, 2024 | Volume: 50 | Issue: 11 | Pages: 1079-1081

10.1097/dss.0000000000004244 | PMID 38754133 Get It

Bibliometric analysis and evaluation of publications on non- Helicobacter pylori helicobacters from 1993 to 2023
Wang, Menghui, Fang, Hui, Zhou, Chulin , Ouyang, Yaobin, Yu, Chenfeng, Zhang, Yang, Zhu, Xiaoyi, Xie, Chuan, Deng, Qiliang, Ouyang, Yaobin , Xie, Chuan

Future Microbiology | May 16, 2024 | Volume: 19 | Issue: 10 | Pages: 889-901

10.2217/fmb-2024-0034 | PMID 38700283 Get It

Secondary tricuspid regurgitation: incidence, types, and outcomes in atrial fibrillation vs. sinus rhythm
Naser, Jwan A. , Castrichini, Matteo , Ibrahim, Hossam H , Scott, Christopher G. , Lin, Grace , Mankad, Rekha , Siontis, Konstantinos C. , Eleid, Mackram F. , Pellikka, Patricia A. , Pislaru, Sorin V. , Mankad, Rekha , Siontis, Konstantinos C , Pellikka, Patricia A , Sabbah, Michael S. , Nkomo, Vuyisile T , Scott, Christopher , Naser, Jwan A , Castrichini, Matteo , Lee, Eunjung , Michelena, Héctor I. , Nkomo, Vuyisile T.

European Heart Journal | May 16, 2024 | Volume: 45 | Issue: 31 | Pages: 2878-2890

10.1093/eurheartj/ehae346 | PMID 38953772 Get It

Abstract Background and Aims Incidence and types of secondary tricuspid regurgitation (TR) are not well defined in atrial fibrillation (AFib) and sinus rhythm (SR). Atrial secondary TR (A-STR) is associated with pre-existing AFib; however, close to 50% of patients with A-STR do not have AFib. The aim of this study was to assess incidence, types, and outcomes of ≥ moderate TR in AFib vs. SR. Methods Adults with and without new-onset AFib without structural heart disease or ≥ moderate TR at baseline were followed for the development of ≥ moderate TR. Tricuspid regurgitation types were pacemaker, left-sided valve disease, left ventricular (LV) dysfunction, pulmonary hypertension (PH), isolated ventricular, and A-STR. Results Among 1359 patients with AFib and 20 438 in SR, 109 and 378 patients developed ≥ moderate TR, respectively. The individual types of TR occurred more frequently in AFib related to the higher pacemaker implantation rates (1.12 vs. 0.19 per 100 person-years, P < .001), larger right atrial size (median 78 vs. 53 mL, P < .001), and higher pulmonary pressures (median 30 vs. 28 mmHg, P < .001). The most common TR types irrespective of rhythm were LV dysfunction-TR and A-STR. Among patients in SR, those with A-STR were older, predominantly women with more diastolic abnormalities and higher pulmonary pressures. All types of secondary TR were associated with all-cause mortality, highest in PH-TR and LV dysfunction-TR. Conclusions New-onset AFib vs. SR conferred a higher risk of the individual TR types related to sequelae of AFib and higher pacemaker implantation rates, although the distribution of TR types was similar. Secondary TR was universally associated with increased mortality.
Interrater reliability of the modified prone instability test for lumbar segmental instability in individuals with mechanical low back pain
Larkin, E , Calley, Darren Q. , Larkin, Ellen R , Hollman, John H.

Journal of Manual & Manipulative Therapy | May 16, 2024 | Volume: 32 | Issue: 5 | Pages: 540-547

10.1080/10669817.2024.2352934 | PMID 38753496 Get It

The use of haploidentical stem cell transplant as an alternative donor source in patients with decreased access to matched unrelated donors
Graham, Christopher , Litzow, Mark

Hematology | May 16, 2024 | Volume: 29 | Issue: 1 | Pages: No page available

10.1080/16078454.2024.2338300 | PMID 38753458 Get It

Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care
Trunk, Andrew D. , Budvytyte, Laura, Khera, Nandita , Hamilton, Betty K. , Islam, N. , Islam, Nadia S, Islam, Nadia , Guo, Michelle , Islam, Nadia S., Amonoo, Hermioni Lokko

American Society of Clinical Oncology Educational Book | May 16, 2024 | Volume: 44 | Issue: 3 | Pages: No page available

10.1200/edbk_432186 | PMID 38754066 Get It

Although allogeneic hematopoietic cell transplantation (HCT) offers a potential for cure for many patients with advanced hematologic malignancies and bone marrow failure or immunodeficiency syndromes, it is an intensive treatment and accompanied by short- and long-term physical and psychological symptoms requiring specialized care. With substantial advances in therapeutic approaches for HCT and supportive care, HCT survivors experience less morbidity and mortality. However, disparities in both HCT access and outcomes persist, and HCT survivors and their caregivers often lack access to much-needed psychosocial care. Additionally, more medical and psychosocial resources are needed to holistically care for HCT survivors with chronic graft-versus-host disease (GVHD). Hence, this chapter focuses on three areas pertaining to advances and gaps in HCT care: disparities in access to and outcomes of HCT, psychosocial and physical symptom management with supportive care interventions, and GVHD prevention and management.